Provided by Tiger Trade Technology Pte. Ltd.

LUYE PHARMA

1.940
-0.190-8.92%
Volume:104.66M
Turnover:202.39M
Market Cap:7.75B
PE:10.47
High:2.125
Open:2.125
Low:1.875
Close:2.130
52wk High:3.940
52wk Low:1.730
Shares:4.00B
HK Float Shares:4.00B
Volume Ratio:2.98
T/O Rate:2.62%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.185
ROE:4.14%
ROA:2.44%
PB:0.41
PE(LYR):10.47
PS:1.05

Loading ...

多部委联合发布房地产新政,美联储主席鹰派信号引发市场关注

Stock News
·
Yesterday

Luye Pharma H1 2026: Revenue Drops 5.6 % to RMB 3.00 B, Net Profit Climbs 6.5 % on Lower Costs; CNS Therapies Lead Growth

Bulletin Express
·
Aug 30

Shandong Boan Biotech Files HKEX Next-Day Return Disclosing Share Buyback at HKD 3.74 Each

Reuters
·
Aug 28

LUYE PHARMA: UBS Group AG Disposes of Shares, Long Position Falls to 12.98%

HK Disclosure
·
Aug 28

Shandong Boan Biotech Enters RMB 75 Million Sale-and-Leaseback Deal with Industrial Bank Financial Leasing

Reuters
·
Aug 27

Luye Pharma's Vaccine for Cervical Precancerous Lesions to Enter Phase II Trial

MT Newswires Live
·
Aug 21

Luye Pharma Sets 29 Aug 2026 Board Meeting to Approve 1H 2026 Results and Review Interim Dividend

Bulletin Express
·
Aug 17

Luye Pharma Schedules Board Meeting to Review Interim Results, Weigh Dividend

Reuters
·
Aug 17

Shandong Boan Biotech Completes China Phase Ia Trial of Ba1302 CD228-Targeted ADC

Reuters
·
Aug 14

Shandong Boan Biotech Schedules Board Meeting on Interim Results, Dividend Review

Reuters
·
Aug 14

Luye Pharma Completes US Bridging Trial for Neurological Drug Candidate

MT Newswires Live
·
Aug 06

Luye Pharma completes U.S. bridging trial for VMAT2/Sigma-1R dual-acting drug LY03015

Bulletin Express
·
Aug 05

Shandong Boan Files Brazil Marketing Application for Ba9101 Aflibercept Biosimilar with Anvisa

Reuters
·
Aug 05

Movement Alert|Luye Pharma Declines 5.41% in Regular Trading, Trading at HK$2.09

Market Focus
·
Jul 17

Movement Alert|Luye Pharma Rises 6.45% in Regular Trading, Convertible Bond Redemption and Positive Clinical Data Drive Three-Day Rally

Market Focus
·
Jul 15

Movement Alert|Luye Pharma Rises 5.29% in Regular Trading, Convertible Bond Redemption and Clinical Progress Fuel Rally

Market Focus
·
Jul 14

Movement Alert|Luye Pharma Rises 5.73% in Regular Trading, Multiple Catalysts Including Bond Redemption and Clinical Milestones Boost Sentiment

Market Focus
·
Jul 13

Shandong Boan Says China CDE Accepts IND Filing for Ba1203 Masked Anti-pd-1/il-2 Fusion Protein

Reuters
·
Jul 08

Luye Pharma Completes Early Redemption of $180 Million Convertible Bonds

MT Newswires Live
·
Jul 07

LUYE PHARMA Successfully Completes Early Redemption of Outstanding US$180 Million Convertible Notes Due 2028

Stock News
·
Jul 06